UnknownNot Applicable

Effects of Transcranial Direct Current Stimulation in Refractory Chronic Migraine and Medication-overuse Headache

30 participantsStarted 2013-02

Plain-language summary

The purpose of the study is to evaluate the efficacy of the transcranial direct current stimulation of the primary motor cortex (M1) in patients affected by refractory chronic migraine (coded as 1.5.1 in the international headache classification 2nd edition, 2004) and medication-overuse headache (coded as 8.1) with migraine as primary headache.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Chronic MIgraine or Medication Overuse Headache according to the diagnostic criteria set out in the 2nd edition of the International Classification of Headache Disorders refractory to treatment according to the Refractory Headache Special Interest Section of the American Headache Society (Schulman et al., 2008) Exclusion Criteria: * Other primary or secondary headaches. * Any serious systemic or neurological disease or psychiatric disorder. * Pregnancy or breastfeeding * Previous or current use of other or similar devices for pain control * Heart conduction and rhythm disorders * Cranial surgery * Other pain conditions, accordingly with current guidelines

What they're measuring

Change in headache days per months

Timeframe: at 30, 60 and 90 days after the treatment

Change in drugs intake per months

Timeframe: at 30, 60 and 90 days after treatment

Trial details

NCT IDNCT01752439

SponsorDr Armando Perrotta, MD, PhD

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-12

View on ClinicalTrials.gov More Chronic Migraine trials